Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fibrogen Inc CS (NQ: FGEN )

0.6154 +0.0354 (+6.10%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fibrogen Inc CS

< Previous 1 2 3 4 5 6 7 8 9 Next >
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. 
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
7 Stocks to Sell Before the Axe Falls
While an uncomfortable topic to discuss, consistent success in the market will require an objective view of stocks to sell. 
Via InvestorPlace
Expert Ratings for FibroGen
Via Benzinga
Preview: FibroGen's Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why REX American Resources Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 89.5% to $2.7852 after the company reported outcomes from a UroShield study conducted at the University of Southampton in the U.K. 
Via Benzinga
Gold Moves Higher; Outlook Therapeutics Shares Plummet
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.14% to 34,900.33 while the NASDAQ rose 0.69% to 14,040.27. The... 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Surges 150 Points; US Economy Grows At 2.1% Pace In Q2
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Wednesday. The Dow traded up 0.44% to 35,006.93 while the NASDAQ rose 0.45% to 14,006.86. The S&P 500, also rose,... 
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
Why NanoVibronix Shares Are Trading Higher By 49%; Here Are 20 Stocks Moving Premarket
Gainers AgileThought, Inc. (NASDAQ: AGIL) rose 96.5% to $0.3046 in pre-market trading after falling 17% on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Three In A Row: FibroGen's Investigational Drug Flunks In Another Study For Rare Disease In Young Boys
Tuesday, FibroGen Inc (NASDAQ: FGEN) announced topline data from the Phase 3 LELANTOS-2 trial of pamrevlumab for ambulatory patients with Duchenne muscular dystrophy (DMD) on  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday morning and we're covering the shares rising and falling this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday, 56 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 54 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 40 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 70 companies achieved new lows for the year. 
Via Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Down 80% in 1 Day, Is There Any Hope for FibroGen Stock?
Its pipeline is looking thin, and it might hit another speed bump quite soon. 
Via The Motley Fool
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review
Major indexes rebounded strongly and many stocks flashed buy signals. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Fibrogen, Inc. and Encourages Investors With Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining more than 50 points on Monday. The Dow traded up 0.18% to 33,788.05 while the NASDAQ fell 0.61% to 13,410.63. The S&P 500,... 
Via Benzinga
Analyst Downgrades FibroGen On Questions Regarding Future Direction
Earlier today, FibroGen Inc (NASDAQ: FGEN) said its Phase 3 ZEPHYRUS-1 trial of pamrevlumab in idiopathic pulmonary fibrosis (IPF) did not meet the primary endpoint of change in forced vital capacity... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks Modestly Lower; Dow Looks To Extend Losing Streak
Stocks are modestly below breakeven this afternoon. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.